Related references
Note: Only part of the references are listed.Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders
G. Sanacora et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Considerations on the Off-label Use of Ketamine as a Treatment forMood Disorders
Samuel T. Wilkinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
C. A. Zarate et al.
MOLECULAR PSYCHIATRY (2017)
New targets for rapid antidepressant action
Rodrigo Machado-Vieira et al.
PROGRESS IN NEUROBIOLOGY (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener et al.
DRUGS (2017)
Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains
Michael R. Weed et al.
NEUROPSYCHOPHARMACOLOGY (2016)
GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
Lakshmi Rajagopal et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
Chadi G. Abdallah et al.
DEPRESSION AND ANXIETY (2016)
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Ewa Poleszak et al.
METABOLIC BRAIN DISEASE (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Antidepressant drug action - From rapid changes on network function to network rewiring
Tomi Rantamaki et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
Kristian Gaarn du Jardin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Daniel Bovet, Nobelist: muscle relaxants in anaesthesia The role played by two neglected protagonists
Dimitri A. Cozanitis
WIENER MEDIZINISCHE WOCHENSCHRIFT (2016)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
Carly Kiselycznyk et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Atypical Neurotransmitters and the Neurobiology of Depression
Samia Regiane Joca et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Recent insights into the mode of action of memantine and ketamine
Jon W. Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
Sheldon Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2015)
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor
Kinga Salat et al.
NEUROPHARMACOLOGY (2015)
THE LONG-LASTING ANTIDEPRESSANT EFFECTS OF RAPASTINEL (GLYX-13) ARE ASSOCIATED WITH A METAPLASTICITY PROCESS IN THE MEDIAL PREFRONTAL CORTEX AND HIPPOCAMPUS
J. Burgdorf et al.
NEUROSCIENCE (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Ketamine and other potential glutamate antidepressants
Arpan Dutta et al.
PSYCHIATRY RESEARCH (2015)
Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test
Vitor Silva Pereira et al.
PSYCHOPHARMACOLOGY (2015)
Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression
Nico Liebenberg et al.
ACTA NEUROPSYCHIATRICA (2015)
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Gerard Sanacora et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy
Caroline Caddy et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
New paradigms for treatment-resistant depression
Carlos Zarate et al.
ANNALS REPORTS (2013)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
From Special K to Special M: The Evolution of the Recreational Use of Ketamine and Methoxetamine
Ornella Corazza et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Tropisetron attenuates amyloid-beta-induced inflammatory and apoptotic responses in rats
Reza Rahimian et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide
Vitor S. Pereira et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
Jeffrey Burgdorf et al.
NEUROPSYCHOPHARMACOLOGY (2013)
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
Xian-Cang Ma et al.
PLOS ONE (2013)
Inhibition of the L-arginine-nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test
Guang-Fen Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
Juan M. Lima-Ojeda et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
Kari R. Nations et al.
Drugs in research & development (2013)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
Rong-Jian Liu et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
Xiaochen Zhao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Lobna Ibrahim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
Kari R. Nations et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf(+/-) heterozygous null mice
Jesse S. O. Lindholm et al.
NEUROPHARMACOLOGY (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats
Jeffrey Burgdorf et al.
NEUROBIOLOGY OF AGING (2011)
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
Alessandro Barbon et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
Valerio Ricci et al.
PSYCHOPHARMACOLOGY (2011)
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls
Francisco A. Moreno et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
Severine Farley et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
Francisco Lopez-Munoz et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
Hussam Jourdi et al.
JOURNAL OF NEUROSCIENCE (2009)
Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice
Oguz Mutlu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Half a century of antidepressant drugs -: On the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics.: Part II:: Tricyclics and tetracyclics
Peter Fangmann et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex
Se Chang Yoon et al.
NEUROSCIENCE LETTERS (2008)
Do ATP and NO interact in the CNS?
F. Florenzano et al.
PROGRESS IN NEUROBIOLOGY (2008)
Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis
Qi-Gang Zhou et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Vittorio Calabrese et al.
NATURE REVIEWS NEUROSCIENCE (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan
PHARMACOLOGY & THERAPEUTICS (2006)
Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects
SRL Joca et al.
PSYCHOPHARMACOLOGY (2006)
The physiology and pathophysiology of nitric oxide in the brain
FX Guix et al.
PROGRESS IN NEUROBIOLOGY (2005)
Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons
LM Mao et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Glutamate signaling to Ras-MAPK in striatal neurons - Mechanisms for inducible gene expression and plasticity
JQ Wang et al.
MOLECULAR NEUROBIOLOGY (2004)
Monoamine depletion in psychiatric and healthy populations: review
L Booij et al.
MOLECULAR PSYCHIATRY (2003)
Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamine-associated psychiatric disorders
B Moghaddam
BIOLOGICAL PSYCHIATRY (2002)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
X Li et al.
NEUROPHARMACOLOGY (2001)
Pharmacotherapy of mental illness - A historical analysis
TA Ban
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)
Pharmacotherapy of depression: a historical analysis
TA Ban
JOURNAL OF NEURAL TRANSMISSION (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats
F Yildiz et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
